Business Description
Amcad Biomed Corp
ISIN : TW0004188008
Description
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from Europe. The company has two segments: Medical diagnostic software: which is responsible for the development and sales of smart medical imaging diagnostic software device and Precision medical equipment: which is responsible for research, development, manufacturing and sales of high-end ultrasonic probes.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.32 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 30.31 | |||||
Beneish M-Score | -2.66 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.6 | |||||
3-Year EBITDA Growth Rate | -3.2 | |||||
3-Year EPS without NRI Growth Rate | -8.4 | |||||
3-Year FCF Growth Rate | 6 | |||||
3-Year Book Growth Rate | -8.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.87 | |||||
9-Day RSI | 53.09 | |||||
14-Day RSI | 52.97 | |||||
6-1 Month Momentum % | -3.66 | |||||
12-1 Month Momentum % | 46.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 15.84 | |||||
Quick Ratio | 14.46 | |||||
Cash Ratio | 14.08 | |||||
Days Inventory | 384.41 | |||||
Days Sales Outstanding | 40.79 | |||||
Days Payable | 16.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.17 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.64 | |||||
Operating Margin % | -92.7 | |||||
Net Margin % | -80.19 | |||||
FCF Margin % | -67.76 | |||||
ROE % | -12.87 | |||||
ROA % | -9.75 | |||||
ROIC % | -28.06 | |||||
ROC (Joel Greenblatt) % | -50.96 | |||||
ROCE % | -9.94 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 23.56 | |||||
PB Ratio | 4.02 | |||||
Price-to-Tangible-Book | 5.01 | |||||
EV-to-EBIT | -24.67 | |||||
EV-to-EBITDA | -38.65 | |||||
EV-to-Revenue | 19.3 | |||||
EV-to-FCF | -28.48 | |||||
Price-to-Net-Current-Asset-Value | 8.09 | |||||
Price-to-Net-Cash | 9.94 | |||||
Earnings Yield (Greenblatt) % | -4.05 | |||||
FCF Yield % | -2.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amcad Biomed Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 62.809 | ||
EPS (TTM) (NT$) | -0.915 | ||
Beta | 0.36 | ||
Volatility % | 54.92 | ||
14-Day RSI | 52.97 | ||
14-Day ATR (NT$) | 0.770038 | ||
20-Day SMA (NT$) | 26.858315 | ||
12-1 Month Momentum % | 46.81 | ||
52-Week Range (NT$) | 16.72817 - 36.586758 | ||
Shares Outstanding (Mil) | 54.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Amcad Biomed Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Amcad Biomed Corp Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Amcad Biomed Corp Frequently Asked Questions
What is Amcad Biomed Corp(ROCO:4188)'s stock price today?
The current price of ROCO:4188 is NT$26.95. The 52 week high of ROCO:4188 is NT$36.59 and 52 week low is NT$16.73.
When is next earnings date of Amcad Biomed Corp(ROCO:4188)?
The next earnings date of Amcad Biomed Corp(ROCO:4188) is .
Does Amcad Biomed Corp(ROCO:4188) pay dividends? If so, how much?
Amcad Biomed Corp(ROCO:4188) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |